Diane Weiser | SVP, Corporate Communications & IR |
Robert Blum | CEO, President & Director |
Fady Malik | EVP, Research & Development |
Stuart Kupfer | SVP & Chief Medical Officer |
Robert Wong | VP & CAO |
Ching Jaw | SVP & CFO |
Salim Syed | Mizuho Securities |
Dane Leone | Raymond James & Associates |
Pete Stavropoulos | Cantor Fitzgerald & Co. |
Hannah Latimer | Morgan Stanley |
Jason Butler | JMP Securities |
Emanuela Branchetti | H.C. Wainwright |
Edward Tenthoff | Piper Sandler & Co. |
Graig Suvannavejh | Goldman Sachs Group |
Gil Blum | Needham & Company |
Good afternoon, and welcome, ladies and gentlemen, to Cytokinetics' Third Quarter 2020 Conference Call. At this time, I would like to inform you that this call is being recorded [Operator Instructions]. I will now turn the call over to Diane Weiser, Cytokinetics Senior Vice President of Corporate Communications and Investor Relations. Please go ahead.
Good afternoon, and thanks for joining us on the call today.